FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces
The FDA in the past year or so has issued draft guidances on regulation of stem cells that would, if finalized, make it crystal clear that what many American stem cell clinics are selling are unapproved drugs. That would be a good thing for patients who are often being put at risk by many of …
FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces Read More »
